An eight-year-old Israeli boy, Meitar Roz, will receive a life-changing therapy for Duchenne muscular dystrophy (DMD) thanks to a massive crowdfunding campaign. The treatment, costing $3.2 million, was not covered by the Israeli state, prompting his parents to launch a public appeal. Meitar’s mother and father, an IDF reservist, spearheaded the fundraising effort which garnered donations from thousands of individuals. The funds raised will enable Meitar to access the critical therapy aimed at slowing the progression of his degenerative disease. The campaign highlights the financial burdens faced by families navigating rare and expensive medical treatments. This successful fundraising initiative offers a beacon of hope for Meitar and his family, allowing him to pursue treatment unavailable through standard healthcare coverage.